184 related articles for article (PubMed ID: 21839643)
1. Synthesis, structure elucidation, determination of the lipophilicity and identification of antitumour activities in vitro of novel 3-(2-furanyl)-8-aryl-7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-ones with a low cytotoxicity towards normal human skin fibroblast cells.
Sztanke K; Tuzimski T; Sztanke M; Rzymowska J; Pasternak K
Bioorg Med Chem; 2011 Sep; 19(17):5103-16. PubMed ID: 21839643
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
5. Lipophilicity of novel antitumour and analgesic active 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione derivatives determined by reversed-phase HPLC and computational methods.
Sztanke K; Markowski W; Swieboda R; Polak B
Eur J Med Chem; 2010 Jun; 45(6):2644-9. PubMed ID: 20172631
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones.
Sztanke K; Pasternak K; Sztanke M; Kandefer-Szerszeń M; Kozioł AE; Dybała I
Bioorg Med Chem Lett; 2009 Sep; 19(17):5095-100. PubMed ID: 19631534
[TBL] [Abstract][Full Text] [Related]
8. Novel derivatives of methyl and ethyl 2-(4-oxo-8-aryl-2H-3,4,6,7-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetates from biologically active 1-aryl-2-hydrazinoimidazolines: synthesis, crystal structure and antiproliferative activity.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Dec; 41(12):1373-84. PubMed ID: 16996655
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure elucidation and identification of antiproliferative activities of a novel class of thiophene bioisosteres bearing the privileged 7,8-dihydroimidazo[2,1-c][1,2,4]triazin-4(6H)-one scaffold.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2015 Jul; 23(13):3448-56. PubMed ID: 25975637
[TBL] [Abstract][Full Text] [Related]
10. Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M; Dybała I; Kozioł AE
Bioorg Med Chem; 2007 Apr; 15(8):2837-49. PubMed ID: 17331732
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity.
Krauth F; Dahse HM; Rüttinger HH; Frohberg P
Bioorg Med Chem; 2010 Mar; 18(5):1816-21. PubMed ID: 20153202
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of reversed-phase HPLC enriched with room temperature imidazolium based ionic liquids for lipophilicity determination of the newly synthesized analgesic active urea derivatives.
Flieger J; Czajkowska-Żelazko A; Rządkowska M; Szacoń E; Matosiuk D
J Pharm Biomed Anal; 2012 Jul; 66():58-67. PubMed ID: 22445825
[TBL] [Abstract][Full Text] [Related]
13. Structure-retention behaviour of biologically active fused 1,2,4-triazinones--correlation with in silico molecular properties.
Sztanke M; Tuzimski T; Janicka M; Sztanke K
Eur J Pharm Sci; 2015 Feb; 68():114-26. PubMed ID: 25528370
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of new 2-aryl-4h-3,1-benzothiazines.
Niewiadomy A; Matysiak J; Karpińska MM
Arch Pharm (Weinheim); 2011 Apr; 344(4):224-30. PubMed ID: 21469171
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis and antitumor evaluation of 2,4-diamino-6-aryl-1,3,5-triazines.
Hu Z; Ma T; Chen Z; Ye Z; Zhang G; Lou Y; Yu Y
J Comb Chem; 2009 Mar; 11(2):267-73. PubMed ID: 19125569
[TBL] [Abstract][Full Text] [Related]
16. Determination of lipophilicity of alpha-(4-phenylpiperazine) derivatives of N-benzylamides using chromatographic and computational methods.
Bajda M; Bucki A; Szlek J; Szwaczkiewicz M; Swierczek M; Malawska B
Biomed Chromatogr; 2008 Apr; 22(4):428-32. PubMed ID: 18059060
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
18. Investigation of lipophilicity of anticancer-active thioquinoline derivatives.
Bajda M; Boryczka S; Wietrzyk J; Malawska B
Biomed Chromatogr; 2007 Feb; 21(2):123-31. PubMed ID: 17120300
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure elucidation and antitumour activity of N-substituted amides of 3-(3-ethylthio-1,2,4-triazol-5-yl)propenoic acid.
Pachuta-Stec A; Rzymowska J; Mazur L; Mendyk E; Pitucha M; Rzaczyńska Z
Eur J Med Chem; 2009 Sep; 44(9):3788-93. PubMed ID: 19482385
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure and anticancer activity of novel alkenyl-1,3,5-triazine derivatives.
Saczewski F; Bułakowska A
Eur J Med Chem; 2006 May; 41(5):611-5. PubMed ID: 16540207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
